Axogen announces first surgical implant of Avive+
Axogen announced the first surgical implantation of its Avive+ Soft Tissue Matrix, a resorbable, multi-layer, placenta-based allograft.
Stay updated with breaking news from Soft Tissue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Axogen announced the first surgical implantation of its Avive+ Soft Tissue Matrix, a resorbable, multi-layer, placenta-based allograft.
Shawn Mendes Spotted with Dr. Jocelyne Miranda for First Time in Months, Seen on Friendly Walk Shawn Mendes and his longtime friend Dr. Jocelyne Miranda are hanging out together again! The 25-year-old “Stitches” hitmaker and the 52-year-old doctor were…
Here's a special advertising feature with a twist of April Fool's Day fun and the chance to win a free night's accommodation for two, valued at $1850 at the award-winning Jamala Wildlife Lodge at the National Zoo and Aquarium.
Soft tissue sarcoma is a rare cancer of connective tissue that can affect soft tissues such as fat, muscle, nerves and blood vessels of any body part.
The company's devices, BioZorb Marker and BioZorb LP Marker, are implanted in soft tissue, including breast tissue, where the site needs to be marked for future procedures, such as radiation for breast cancer treatment. The Food and Drug Administration said it has received reports on complications related to the use of the devices in breast tissue including infection, fluid buildup, device moving out of its position and breaking through the skin. It has also received reports of pain, discomfort from feeling the device in the breast along with the need for additional medical treatment fo...